KETEK

Ketek

Comments On Article

This paper is to comment on an article “The FDA and the Case of Ketek”by Dr. Ross published in New England Journal of Medicine. Dr. Ross B. David, who is a clinical assistant professor discussed the issue of a drug “Ketek”(a ketolide antibiotic) produced by Sanofi-Aventis. The drug was suggested for utilize in society-obtained respiratory tract infections.

In April 2006, in the USA the and FDA recognized twelve cases of severe failure of liver, ensuing 04 deaths, and an extra twenty-three cases of severe liver damage in patients taking the drug. Ketek (Telithromycin) had caused Eighteen demises and at ...